Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Non-Current Deffered Revenue (2024 - 2025)

Volitionrx filings provide 2 years of Non-Current Deffered Revenue readings, the most recent being $21.9 million for Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue fell 3.2% to $21.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.9 million, a 3.2% decrease, with the full-year FY2025 number at $21.9 million, down 3.2% from a year prior.
  • Non-Current Deffered Revenue hit $21.9 million in Q4 2025 for Volitionrx, roughly flat from $22.0 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $22.7 million in Q4 2024 to a low of $21.9 million in Q4 2025.